3.67
+0.11(+3.09%)
Currency In USD
| Previous Close | 3.56 |
| Open | 3.5 |
| Day High | 3.78 |
| Day Low | 3.4 |
| 52-Week High | 8.6 |
| 52-Week Low | 1.71 |
| Volume | 41,484 |
| Average Volume | 855,873 |
| Market Cap | 10.12M |
| PE | -0.44 |
| EPS | -8.4 |
| Moving Average 50 Days | 4.07 |
| Moving Average 200 Days | 3.27 |
| Change | 0.11 |
If you invested $1000 in Sintx Technologies, Inc. (SINT) 10 years ago, it would be worth $0 as of November 11, 2025 at a share price of $3.67. Whereas If you bought $1000 worth of Sintx Technologies, Inc. (SINT) shares 5 years ago, it would be worth $0.11 as of November 11, 2025 at a share price of $3.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System
GlobeNewswire Inc.
Nov 03, 2025 1:00 PM GMT
Clinical evaluation of the product by design surgeons completed, driving early commercial momentum SALT LAKE CITY, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced cera
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
GlobeNewswire Inc.
Oct 20, 2025 11:00 AM GMT
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ce
UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market
GlobeNewswire Inc.
Oct 16, 2025 11:00 AM GMT
New U.S. Patent reinforces competitive advantage and enables broader licensing and product opportunities across key markets SALT LAKE CITY, Utah, Oct. 16, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”),